Dropped GLP-1 Coverage Leaves Workers 'Terrified'
AI Image

Dropped GLP-1 Coverage Leaves Workers 'Terrified'

Newser • • health

Key Points:

  • Employers are increasingly reducing or eliminating coverage for GLP-1 weight-loss drugs like Wegovy and Zepbound due to rising health care costs, with coverage among large employers dropping from 72% in 2025 to 60% this year.
  • Major companies such as Starbucks, UPS, PepsiCo, and Comcast are among those scaling back benefits for these medications, citing rapid expense growth as a key reason.
  • Health experts and obesity advocates warn that cutting coverage creates disparities, leaving only those who can afford high out-of-pocket costs able to access treatment for a chronic disease.
  • Patients report resorting to discount programs, dose stretching, or discontinuing medication altogether, expressing fear about the potential negative impact on their health.
  • The situation highlights a growing tension between employer cost management and patient access to effective weight-loss treatments.

Trending Business

Trending Technology

Trending Health